Nonsustained ventricular tachycardia in the setting of acute myocardial infarction: Tachycardia characteristics and their prognostic implications

Circulation

Volumn 98, Issue 19, 1998, Pages 2030-2036

  Cheema, Asim N ^a   Sheu, Kathleen ^a   Parker, Michele ^a   Kadish, Alan H ^a   Goldberger, Jeffrey J ^a,b  

^a NORTHWESTERN UNIVERSITY   (United States)

^b NORTHWESTERN MEMORIAL HOSPITAL   (United States)

Author keywords

Myocardial infarction; Prognosis; Risk factors; Tachycardia

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; FIBRINOLYTIC AGENT; LIDOCAINE; PROCAINAMIDE;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; DATA BASE; DISEASE DURATION; FEMALE; FIBRINOLYTIC THERAPY; FOLLOW UP; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HOSPITALIZATION; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; PROGNOSIS; Q WAVE; RISK ASSESSMENT;

EID: 0032506266     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.98.19.2030     Document Type: Article

References (22)

1. Bigger J, Dresdale R, Heissenbuttel R, Weld F, Wit A. Ventricular arrhythmias in ischemic heart disease: mechanism, prevalence, significance, and management. Prog Cardiovasc Dis. 1977;19:255-300.
2. Pasternak R, Braunwald E. Complications of myocardial infarction and their treatment. In: Isselbacher K, Braunwald E, Wilson J, Martin J, Fauci A, Kasper D, eds. Harrison's Principles of Internal Medicine. 13th ed. New York, NY: McGraw-Hill Inc; 1994:1071.
3. Eldar M, Sievner Z, Goldbourt U, Reicher-Reiss H, Kaplinsky E, Behar S. Primary ventricular tachycardia in acute myocardial infarction: clinical characteristics and mortality. Ann Intern Med. 1992;117:31-36.
4. Mont L, Cinca J, Blanch P, Blanco J, Figueras J, Brotons C, Soler-Soler J. Predisposing factors and prognostic value of sustained monomorphic ventricular tachycardia in the early phase of acute myocardial infarction. J Am Coll Cardiol. 1996;28:1670-1676.
5. Wolfe C, Nibley C, Bhandari A, Chatterjee K, Scheinman M. Polymorphous ventricular tachycardia associated with acute myocardial infarction. Circulation. 1991;84:1543-1551.
6. MacMahon S, Collins R, Peto R, Koster R, Yusuf S. Effects of prophylactic lidocaine in suspected acute myocardial infarction. JAMA. 1988; 260:1910-1916.
7. Campbell R, Murray A, Julian D. Ventricular arrhythmias in the first 12 hours of acute myocardial infarction. Br Heart J. 1981;46:351-357.
8. Volpi A, Maggioni A, Franzosi M, Pampallona S, Mauri F, Tognoni G. In-hospital prognosis of patients with acute myocardial infarction complicated by primary ventricular fibrillation. N Engl J Med. 1987;317: 257-261.
9. Behar S, Goldbourt U, Reicher-Reiss H, Kaplinsky E. Prognosis of acute myocardial infarction complicated by primary ventricular fibrillation. Am J Cardiol. 1990;66:1208-1211.
10. Volpi A, Cavalli A, Franzosi M, Maggioni A, Mauri F, Santoro E, Tognoni G. One-year prognosis of primary ventricular fibrillation complicating acute myocardial infarction. Am J Cardiol. 1989;63: 1174-1178.
11. de Soyza N, Bissett J, Kane J, Murphy M, Doherty J. Ectopic ventricular prematurity and its relationship to ventricular tachycardia in acute myocardial infarction in man. Circulation. 1974;50:529-533.
12. Heidbuchel H, Tack J, Vanneste L, Ballet A, Ector H, VandeWerf F. Significance of arrhythmias during the first 24 hours of acute myocardial infarction treated with alteplase and effect of early administration of a β-blocker or a bradycardiac agent on their incidence. Circulation. 1994; 89:1051-1059.
13. Bigger T, Fleiss J, Kleiger R, Miller P, Rolintzky L, and the Multicenter Posllnfarction Research Group. The relationship among ventricular arrhythmias, left ventricular dysfunction, and mortality in the two years after myocardial infarction. Circulation. 1984;69:250-258.
14. Bigger J, Weld F, Rolnitzky L. Prevalence, characteristics, and significance of ventricular tachycardia (three or more complexes) detected with ambulatory electrocardiographic recording in the late phase of acute myocardial infarction. Am J Cardiol. 1981;48: 815-823.
15. Bigger T, Fleiss J, Rolnitzky L, and the Multicenter Postlnfarction Research Group. Prevalence, characteristics and significance of ventricular tachycardia detected by 24-hour continuous electrocardiographic recordings in the late hospital phase of acute myocardial infarction. Am J Cardiol. 1986;58:1151-1160.
16. Epstein A, Carlson M, Fogoros R, Higgins S, Venditti F. Classification of death in antiarrhythmic trials. J Am Coll Cardiol. 1996;27:433-442.
17. Pratt C, Greenway P, Schoenfeld M, Hibben M, Reiffel J. Exploration of the precision of classifying sudden cardiac death: implications for the interpretation of clinical trials. Circulation. 1996;93:519-524.
18. Ehlert F, Goldberger J. Cellular and pathophysiological mechanisms of ventricular arrhythmias in acute ischemia and infarction. Pacing Clin Elearophysiol. 1997:20:966-975.
19. Doval H, Nul D, Grancelli H, Varini S, Soifer S, Corrado G, Dubner S, Scapin O, Perrone S. Nonsustained ventricular tachycardia in severe heart failure: independent marker of increased mortality due to sudden death. Circulation. 1996;94:3198-3203.
20. Ryan T, Anderson J, Antman E, Braniff B, Brooks N, Califf R, Hillis D, Hiratzka L, Rapaport E, Riegel B, Russell R, Smith E, Weaver W. ACC/AHA guidelines for the management of patients with acute myocardial infarction: a report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction). J Am Coll Cardiol. 1996:28:1328-1428.
21. Deedwania P, Amsterdam E, Vagelos R. Evidence-based, cost effective risk stratification and management after myocardial infarction. Arch Intern Med. 1997;157:273-280.
22. Peterson E, Shaw L, Califf R. Risk stratification after myocardial infarction. Ann Intern Med. 1997:126:561-582.